Table 1. Clinical characteristics from... | American Society of Hematology

Table 1.

Clinical characteristics from patients and controls included in our study and their JAG2 status

BM no.	BM % cellularity	% plasma cells	Clinical diagnosis	Monoclonal protein	JAG2 overexpression
Control samples
9091	30	4	No PCD	-	-
4666	30	3	No PCD	-	-
4502	40	7	PV	-	-
7812	30	5	HD	-	-
3201	N/A	1	Tonsil	-	-
4790	N/A	2	Tonsil	-	-
1980	30	3	No PCD	-	-
3205	50	1	NHL	IgA kappa	-
1409	30	6	Breast cancer	-	-
Patient samples
8961	45	4	MGUS	IgA kappa	+
1130	30	10	MGUS	IgG kappa	+
9768	30	4	MGUS	IgA lambda	+
1154	30	5	MGUS	IgG kappa	+
073886	30	10	MGUS	IgA lambda	+
9625	40	5	sMM	IgG lambda	+
0838	80	75	MM	IgA kappa	+
6368	40	14	MM	IgG lambda	+
1332965	70	25	MM	IgG lambda	+
2477	50	31	MM	IgG lambda	+
1291	70	17	MM	IgG kappa	+
4087	30	31	MM	IgG kappa	+
4438	> 90	66	MM	IgG lambda	+
13544	> 90	90	MM	IgG kappa	+
2976	60	4	MM treated	IgA kappa	+
1906	40	3	MM in remission	IgG kappa	+
2247	70	7	MM treated	IgG kappa	+

BM no.	BM % cellularity	% plasma cells	Clinical diagnosis	Monoclonal protein	JAG2 overexpression
Control samples
9091	30	4	No PCD	-	-
4666	30	3	No PCD	-	-
4502	40	7	PV	-	-
7812	30	5	HD	-	-
3201	N/A	1	Tonsil	-	-
4790	N/A	2	Tonsil	-	-
1980	30	3	No PCD	-	-
3205	50	1	NHL	IgA kappa	-
1409	30	6	Breast cancer	-	-
Patient samples
8961	45	4	MGUS	IgA kappa	+
1130	30	10	MGUS	IgG kappa	+
9768	30	4	MGUS	IgA lambda	+
1154	30	5	MGUS	IgG kappa	+
073886	30	10	MGUS	IgA lambda	+
9625	40	5	sMM	IgG lambda	+
0838	80	75	MM	IgA kappa	+
6368	40	14	MM	IgG lambda	+
1332965	70	25	MM	IgG lambda	+
2477	50	31	MM	IgG lambda	+
1291	70	17	MM	IgG kappa	+
4087	30	31	MM	IgG kappa	+
4438	> 90	66	MM	IgG lambda	+
13544	> 90	90	MM	IgG kappa	+
2976	60	4	MM treated	IgA kappa	+
1906	40	3	MM in remission	IgG kappa	+
2247	70	7	MM treated	IgG kappa	+

PCD indicates plasma cell disorder; PV, polycythemia vera; HD, Hodgkin disease; N/A, not applicable; NHL, non-Hodgkin lymphoma; sMM, smoldering MM.

+ indicates positive; - indicates negative.